DPP9 and COVID-19: We suspect that lower DPP9 may exacerbate pathogenesis of IPF and COVID-19 by preventing excess NLRP1-mediated inflammation and weakening cell-to-cell adhesion, promoting a dysregulated cycle of inflammation and fibrosis (Figure S3B).